Cargando…
Pyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patient
BRCA1 promoter methylation is an essential epigenetic transcriptional silencing mechanism, related to breast cancer (BC) occurrence and progression. We quantified the methylation level of BRCA1 promoter and evaluated its significance as prognostic and predictive factor. BRCA1 promoter methylation le...
Autores principales: | Cai, Feng-Feng, Chen, Su, Wang, Ming-Hong, Lin, Xiao-Yan, Zhang, Lian, Zhang, Jia-Xin, Wang, Lian-Xin, Yang, Jun, Ding, Jin-Hua, Pan, Xin, Shao, Zhi-Ming, Biskup, Ewelina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053667/ https://www.ncbi.nlm.nih.gov/pubmed/27027444 http://dx.doi.org/10.18632/oncotarget.8355 |
Ejemplares similares
-
Pyrosequencing quantified methylation level of miR-124 predicts shorter survival for patients with myelodysplastic syndrome
por: Wang, Hong, et al.
Publicado: (2017) -
Mammalian sterile 20-like kinase 1 expression and its prognostic significance in patients with breast cancer
por: Lin, Xiao-Yan, et al.
Publicado: (2017) -
Prognostic value of plasma levels of HIF-1a and PGC-1a in breast cancer
por: Cai, Feng-Feng, et al.
Publicado: (2016) -
Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing
por: Shaw, Richard J., et al.
Publicado: (2006) -
The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma
por: Yu, Zhi-Hao, et al.
Publicado: (2021)